We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current ELAN market cap is 6.54B. The company's latest EPS is USD -2.4971 and P/E is -5.31.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.03B | 981M | 1.26B | 1.06B | 1.07B |
| Operating Income | 27M | -96M | 181M | 18M | -1.01B |
| Net Income | -13M | -91M | 103M | -97M | -1.1B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 3.07B | 3.28B | 4.77B | 4.41B | 4.42B |
| Operating Income | 174.3M | -696.1M | -48M | 201M | -817M |
| Net Income | 67.9M | -560.1M | -472M | -78M | -1.23B |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 14.95B | 15.49B | 15.77B | 15.8B | 14.34B |
| Total Liabilities | 8.2B | 8.2B | 8.29B | 8.38B | 8.21B |
| Total Equity | 6.75B | 7.29B | 7.48B | 7.42B | 6.13B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 8.99B | 17.69B | 16.48B | 15.49B | 14.36B |
| Total Liabilities | 3.44B | 9.22B | 8.95B | 8.2B | 8.14B |
| Total Equity | 5.55B | 8.48B | 7.54B | 7.29B | 6.22B |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 439M | 452M | -145M | -84M | 114M |
| Investing | -103M | -179M | -55M | -98M | -134M |
| Financing | -465M | -549M | 174M | 213M | 56M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 224.1M | -41M | 483M | 452M | 271M |
| Investing | -234.8M | -4.78B | -530M | -179M | -169M |
| Financing | -304.8M | 4.95B | 210M | -549M | -83M |
| Market Cap | 6.54B |
| Price to Earnings Ratio | -5.31 |
| Price to Sales Ratio | 1.48 |
| Price to Cash Ratio | 18.57 |
| Price to Book Ratio | 1.05 |
| Dividend Yield | - |
| Shares Outstanding | 492.97M |
| Average Volume (1 week) | 4.19M |
| Average Volume (1 Month) | 4.31M |
| 52 Week Change | 41.21% |
| 52 Week High | 16.88 |
| 52 Week Low | 7.88 |
| Spread (Intraday) | 0.26 (1.92%) |
| Company Name | Elanco Animal Health Incorporated |
| Address |
135 north pennsylvania street indianapolis, indiana 46204 |
| Website | https://www.elanco.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
